Cite
HARVARD Citation
Esch, E. et al. (n.d.). EP330/#475 Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions. International journal of gynecological cancer. pp. A187-A188. [Online].